By Jessica Newman2021-07-05T10:38:00
A portfolio of 14 pharmacy investments is expected to go under the hammer at Acuitus’s sale later this month, demonstrating the demand for pharmacy-backed properties.
You must be logged in to continue
Register for free to finish this article.
Sign up now for the following benefits:
To access this article REGISTER NOW
Would you like print copies, app and digital replica access too? SUBSCRIBE for as little as £6 per week.
Registered users and subscribers SIGN IN here to continue
Site powered by Webvision Cloud